XFOR financials
X4 Pharmaceuticals (XFOR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- XFOR revenue was $35.11M in fiscal 2025, net income -$79.20M.
XFOR income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $35.11M | $29.36M | -$86.88M | -$79.20M | -1.87 |
| 2024 | $2.56M | $1.76M | -$36.40M | -$37.45M | -5.59 |
| 2023 | $0.00 | $0.00 | -$107.52M | -$101.17M | -17.07 |
| 2022 | $0.00 | $0.00 | -$87.57M | -$96.41M | -45.60 |
| 2021 | $0.00 | – | -$85.11M | -$102.64M | -119.70 |
| 2020 | $3.00M | – | -$59.87M | -$62.13M | -92.70 |